Skip to main content
Journal cover image

Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content.

Publication ,  Journal Article
Boudewyns, V; Betts, KR; Johnson, M; Paquin, RS; O'Donoghue, AC; Southwell, BG
Published in: Res Social Adm Pharm
April 2021

BACKGROUND: Consumers and primary care physicians (PCPs) sometimes encounter deceptive promotional claims about prescription drugs. Whether consumers and PCPs can detect deceptive claims or whether those claims negatively affect medical decision making, however, remain important, unanswered research questions. OBJECTIVES: This article explores (1) the ability of consumers and PCPs to identify deceptive prescription drug promotion at various levels of deception, (2) the influence of such tactics on obstructing risk recognition, and (3) whether perceived deception mediates relationships between exposure to deceptive tactics and various outcomes (including false-claim acceptance, attitudes, information-seeking intentions, and interest toward the promoted drug). METHODS: Two experiments-1 with consumers (N = 366) and 1 with PCPs (N = 378)-were conducted to determine whether participant exposure to deceptive prescription drug website content corresponds to detection and acceptance (or rejection) of claims and tactics. In each experiment, the number of deceptive claims and tactics on a consumer- or PCP-targeted website for a fictitious chronic pain medication were varied, in a 1 × 3 (none, fewer, more) between-subjects design. RESULTS: Among consumers, exposure to more deceptive claims or tactics did not increase suspicion about the veracity of the website (relative to fewer claims and tactics) and actually had a limited positive direct effect on false-claim acceptance and attitudes toward the drug. Among PCPs, a mediation effect existed such that exposure to more deceptive claims and tactics resulted in higher perceived website deceptiveness relative to those in the fewer deceptive claims condition, which, in turn, resulted in lower acceptance of deceptive claims and tactics, lower perceived drug effectiveness, more negative attitudes toward the drug, and lower interest and intentions. CONCLUSION: These experiments demonstrate potential differences between consumers and PCPs as well as implications for consumer and PCP vulnerability to website deception.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Res Social Adm Pharm

DOI

EISSN

1934-8150

Publication Date

April 2021

Volume

17

Issue

4

Start / End Page

733 / 743

Location

United States

Related Subject Headings

  • Prescription Drugs
  • Physicians
  • Pharmacology & Pharmacy
  • Intention
  • Humans
  • Attitude
  • 4206 Public health
  • 4203 Health services and systems
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Boudewyns, V., Betts, K. R., Johnson, M., Paquin, R. S., O’Donoghue, A. C., & Southwell, B. G. (2021). Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content. Res Social Adm Pharm, 17(4), 733–743. https://doi.org/10.1016/j.sapharm.2020.06.019
Boudewyns, Vanessa, Kevin R. Betts, Mihaela Johnson, Ryan S. Paquin, Amie C. O’Donoghue, and Brian G. Southwell. “Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content.Res Social Adm Pharm 17, no. 4 (April 2021): 733–43. https://doi.org/10.1016/j.sapharm.2020.06.019.
Boudewyns V, Betts KR, Johnson M, Paquin RS, O’Donoghue AC, Southwell BG. Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content. Res Social Adm Pharm. 2021 Apr;17(4):733–43.
Boudewyns, Vanessa, et al. “Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content.Res Social Adm Pharm, vol. 17, no. 4, Apr. 2021, pp. 733–43. Pubmed, doi:10.1016/j.sapharm.2020.06.019.
Boudewyns V, Betts KR, Johnson M, Paquin RS, O’Donoghue AC, Southwell BG. Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content. Res Social Adm Pharm. 2021 Apr;17(4):733–743.
Journal cover image

Published In

Res Social Adm Pharm

DOI

EISSN

1934-8150

Publication Date

April 2021

Volume

17

Issue

4

Start / End Page

733 / 743

Location

United States

Related Subject Headings

  • Prescription Drugs
  • Physicians
  • Pharmacology & Pharmacy
  • Intention
  • Humans
  • Attitude
  • 4206 Public health
  • 4203 Health services and systems
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences